Scientific Advisory Board
Michael M. Lederman, M.D.
Professor of Medicine at Case Western Reserve University
Dr. Michael M. Lederman is associate director of the Center for AIDS Research at Case Western Reserve University, where he has directed the AIDS Clinical Trials Unit since its founding in 1987. He is also a Scott R. Inkley Professor of Medicine, Professor of Pathology, Molecular Biology/Microbiology and Biomedical Ethics at the University. He has been engaged in AIDS research and care since 1983 , when he described sub clinical immune deficiency in otherwise healthy men with hemophilia together with Oscar Ratnoff. His work has focused on the mechanisms of immune deficiency and immune restoration in HIV infection and more recently on the feasibility of CCR5 sequestration as a topical strategy to prevent HIV transmission. Dr. Lederman serves on multiple advisory boards including the Scientific Advisory Board of the Agence Nationale de Research sur SIDA (ANRS), the Forum for Collaborative Research and the Wellcome Trust Tropical and Clinical Immunology and Infectious Diseases Funding Committee. Dr. Lederman received his degree in medicine from the Mt. Sinai School of Medicine and served as intern, resident, chief resident in Medicine and fellow in Infectious Diseases at Case where he joined the faculty in 1980.
Robert L. Murphy, M.D.
Professor of Infectious Diseases at Northwestern University
Dr. Robert L. Murphy is the John P. Phair Professor of Infectious Diseases and a director of global health research at Northwestern University. He is also Principal Investigator for the National Institutes for Allergy and Infectious Diseases (NIAID) Adult AIDS Clinical Trials Group (ACTG) at Northwestern and has been involved with the development of over 80% of drugs used to treat HIV and viral hepatitis. His primary research interests are in viral infections, including development of new antiretroviral drugs, anti-hepatitis agents, and therapeutic vaccines; antiviral therapy complications; and therapy scale up for AIDS, tuberculosis and malaria in sub-Saharan Africa.
Dr. Murphy received his B.A. from Boston University and an M.D. from Loyola University. He completed his postgraduate training in Internal Medicine and Infectious Diseases at Northwestern University.
Giuseppe Pantaleo, M.D.
Professor of Medicine at Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Switzerland
Dr. Giuseppe Pantaleo is a Professor of Medicine, Chief of the Division of Immunology and Allergy, and Chief of the Laboratory of AIDS Immunopathogenesis at the Centre Hospitalier Universitaire Vaudois (CHUV), part of the University of Lausanne, Switzerland. During the past ten years, Professor Pantaleo's has been focused on the delineation of the immunopathogenesis of HIV infection. Dr. Pantaleo has received many prestigious awards during his career, including the National Institutes of Health (NIH) Director's Award in 1996. Dr. Pantaleo is one of the main initiators of the Swiss Institute for Vaccine Research (SIVR) and, where he is Executive Director.
Professor Pantaleo received a degree in medicine with full marks and honors from the University of Bari Medical School, University of
Bari (Italy), and in 1983, obtained the Board in Clinical Hematology at the University
|Home | About Us | Technology | DermaVir | Clinical Trials | Pipeline | Newsroom | Contacts | Site Map||Last Update: May 8, 2009|